Benjamin Looker - General Counsel at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
ESPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Benjamin Looker since 11/21/2023

Holdings reported by Benjamin Looker for Esperion Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 184K $104K $1.25 Mar 14, 2024 Direct
Stock Option (right to buy) 150K Mar 14, 2024 Direct Common Stock

Transactions reported by Benjamin Looker for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.